Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial

Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: An observer-blind, phase 3 randomised clinical trial

अन्य संस्करण दिखाएं (1)

Background Meningococcal conjugate vaccines protect individuals directly, but can also confer herd protection by interrupting carriage transmission. We assessed the effects of meningococcal quadrivalent glycoconjugate (MenACWY-CRM) or serogroup B (4CMenB) vaccination on meningococcal carriage rates...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों: Read, R, Baxter, D, Chadwick, DR, Faust, SN, Finn, A, Gordon, S, Heath, P, Lewis, D, Pollard, A, Turner, D, Bazaz, R, Ganguli, A, Havelock, T, Neal, K, Okike, I, Morales-Aza, B, Patel, K, Snape, MD, Williams, J, Gilchrist, S, Gray, S, Maiden, M, Toneatto, D, Wang, H, McCarthy, M
स्वरूप: Journal article
भाषा:English
प्रकाशित: Lancet 2014
विवरण
सारांश:Background Meningococcal conjugate vaccines protect individuals directly, but can also confer herd protection by interrupting carriage transmission. We assessed the effects of meningococcal quadrivalent glycoconjugate (MenACWY-CRM) or serogroup B (4CMenB) vaccination on meningococcal carriage rates in 18-24-year-olds.

समान संसाधन